![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.globenewswire.com/news-release/2022/10/26/2541822/0/en/Acer-Therapeutics-Receives-Notice-of-Allowance-of-Key-US-Patent-Application-Covering-EDSIVO-celiprolol.html
https://www.globenewswire.com/news-release/2022/04/04/2415756/0/en/Acer-Therapeutics-EDSIVO-celiprolol-Granted-FDA-Breakthrough-Therapy-Designation-for-Vascular-Ehlers-Danlos-Syndrome.html
https://www.biospace.com/article/following-crl-acer-therapeutics-restructures-company-lays-off-29/
https://www.fiercebiotech.com/biotech/fda-kicks-back-acer-s-rare-disease-drug-demands-new-test-shares-freefall
https://endpts.com/fda-rejects-acers-rare-drug-asks-for-new-trial/
https://www.biocentury.com/bc-extra/company-news/2018-12-26/fda-accepts-acer-kala-ndas-funding-lapse
http://www.businesswire.com/news/home/20160510005490/en/Acer-Therapeutics-Closes-8.15-Million-Series-Financing